As summarized in Figure 8, this complex was shown to curb oxLDL-induced LOX-1-mediated signaling pathways with subsequent inhibition of NOX2-dependent inflammation, reduction in mitochondrial oxidative stress, and extinction of macrophage-driven inflammatory activity, suggesting its potential in the treatment of chronic inflammatory diseases such as atherosclerosis. This evidence concerns the gene CYBB and atherosclerosis.